Published in J Clin Microbiol on June 01, 1988
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest (1990) 3.03
The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest (1997) 1.76
Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun (1993) 1.55
Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii. Antimicrob Agents Chemother (1993) 1.54
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infect Immun (1992) 1.44
Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest (1990) 1.37
Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun (2003) 1.29
Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest (1991) 1.29
Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun (1993) 1.28
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun (1995) 1.18
Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. J Clin Microbiol (1993) 1.17
Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest (1990) 1.17
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. Antimicrob Agents Chemother (1991) 1.15
An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivo. J Clin Microbiol (1992) 1.15
Inhibitors of delta24(25) sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii. Antimicrob Agents Chemother (1997) 1.13
Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother (1998) 1.11
Pneumocystis carinii organisms obtained from rats, ferrets, and mice are antigenically different. Infect Immun (1993) 1.09
Phytosterols are present in Pneumocystis carinii. Antimicrob Agents Chemother (1994) 1.07
Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrob Agents Chemother (1994) 1.04
Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats. Infect Immun (2003) 1.04
Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. Infect Immun (1992) 1.01
Comparative study of antipneumocystis agents in rats by using a Pneumocystis carinii-specific DNA probe to quantitate infection. J Clin Microbiol (1992) 1.00
Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clin Diagn Lab Immunol (2003) 0.99
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1996) 0.95
8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1993) 0.95
Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J Clin Invest (1993) 0.94
Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun (1999) 0.93
Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection. Infect Immun (1996) 0.91
Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun (2003) 0.91
Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob Agents Chemother (1993) 0.91
Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun (1994) 0.90
Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia. Clin Diagn Lab Immunol (1998) 0.89
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin Diagn Lab Immunol (1994) 0.88
Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. J Biol Chem (2009) 0.86
Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages. BMC Microbiol (2010) 0.86
Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages. Infect Immun (2004) 0.85
Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model. Antimicrob Agents Chemother (1998) 0.82
Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection. Infect Immun (1991) 0.80
IMP dehydrogenase from Pneumocystis carinii as a potential drug target. Antimicrob Agents Chemother (1997) 0.80
Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia. Infect Immun (2009) 0.79
Polyamine transport as a target for treatment of Pneumocystis pneumonia. Antimicrob Agents Chemother (2009) 0.79
Retrospective Analysis of Bacterial and Viral Co-Infections in Pneumocystis spp. Positive Lung Samples of Austrian Pigs with Pneumonia. PLoS One (2016) 0.77
Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats. J Clin Microbiol (1991) 0.77
Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages. Inflammation (1997) 0.76
Alteration in expression of the rat mitochondrial ATPase 6 gene during Pneumocystis carinii infection. BMC Microbiol (2001) 0.75
Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest (1966) 7.58
Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (1977) 2.16
Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Science (1985) 2.07
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii. Infect Immun (1985) 1.45
Activation and transmission in rats of infection with Pneumocystis. Proc Soc Exp Biol Med (1971) 1.36
Improved rat model for studying Pneumocystis carinii pneumonia. J Clin Microbiol (1987) 1.27
Sources of rats free of latent Pneumocystis carinii. J Clin Microbiol (1987) 1.14
Extended use of nursing services in general practice. Br Med J (1967) 6.35
The practice nurse--a new look. Br Med J (1970) 5.16
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (1998) 5.03
Ligand binding to integrins. J Biol Chem (2000) 4.94
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33
Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A (2001) 3.23
Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest (1975) 2.88
Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73
Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24
General practitioners in hospital. Br Med J (1970) 2.22
Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12
Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol (1998) 2.10
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Radioimmunoassay for prostaglandins. Science (1971) 1.99
A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (1996) 1.96
Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
The influence of a competitor on the geographic mosaic of coevolution between crossbills and lodgepole pine. Evolution (2001) 1.93
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis (2010) 1.88
Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis (1985) 1.78
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
THE CATEGORY OF TOPOLOGICAL OBJECTS. Proc Natl Acad Sci U S A (1961) 1.73
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Alcohol and other substance abuse and impairment among physicians in residency training. Ann Intern Med (1992) 1.72
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
Observations on the collagen and proteinpolysaccharide complex of rabbit cornea stroma. J Cell Sci (1969) 1.70
HIV transmitted by sexual intercourse but not by kissing. Br Med J (Clin Res Ed) (1987) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Comparative study of district and community hospitals. Br Med J (1973) 1.67
Integrin-mediated cell adhesion: the extracellular face. J Biol Chem (1994) 1.66
Anthranilate synthase enzyme system and complementation in Pseudomonas species. Proc Natl Acad Sci U S A (1970) 1.65
Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1988) 1.64
Growth and toxin production of Tetanus bacilli in vivo. J Med Microbiol (1974) 1.63
Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol (1990) 1.61
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis (1997) 1.60
Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem (1994) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med (1978) 1.59
Excess morbidity and mortality associated with influenza in England and Wales. Lancet (1980) 1.57
Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer (2000) 1.56
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
Observations on the distribution of the proteinpolysaccharide complex and collagen in bovine articular cartilage. J Cell Sci (1967) 1.54
Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem (2001) 1.54
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol (1991) 1.53
Observations on the morphology of the proteinpolysaccharide complex of bovine nasal cartilage and its relationship to collagen. Proc R Soc Lond B Biol Sci (1966) 1.53
The beta-tubulin gene from rat and human isolates of Pneumocystis carinii. Mol Microbiol (1992) 1.52
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol (1997) 1.52
Mechanism of integrin activation by disulfide bond reduction. Biochemistry (2001) 1.51
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant (2007) 1.51
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
Frequency of immediate adverse effects associated with apheresis donation. Transfusion (1998) 1.49
Experimental abortion and the systemic immune response to "Haemophilus somnus" in cattle. Infect Immun (1986) 1.48
Comparative evaluation of a modified zinc sulfate flotation technique. J Clin Microbiol (1978) 1.48
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem (1995) 1.47
Molecular pattern in native collagen. Nature (1968) 1.47
Immediate breast reconstruction: reducing the risks. Plast Reconstr Surg (1989) 1.47
Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2. J Clin Oncol (1993) 1.46
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology (1994) 1.46
Survival of urinary leucocytes. J Clin Pathol (1966) 1.45
Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol (1995) 1.45
Aflatoxicosis in the broiler chicken. Poult Sci (1970) 1.45
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS (1998) 1.44
Evaluation of the protective value of hospital gowns against blood strike-through and methicillin-resistant Staphylococcus aureus penetration. Am J Infect Control (1998) 1.44
Immunity of children to diphtheria, tetanus, and poliomyelitis. Br Med J (1979) 1.44